Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.
Data will appear here once earnings are reported.

OTCQXZCOR
All numbers in thousands USD
Period Ending
Mar 31, 2019
Dec 31, 2018
Sep 30, 2018
Jun 30, 2018
Total Revenue
--
8,496
8,153
7,443
Cost of Revenue
--
1,894
1,773
1,565
Gross Profit
--
6,602
6,380
5,878
Operating Expenses
Research Development
--
278
956
999
Selling General and Administrative
--
18,240
13,488
15,713
Non Recurring
--
--
--
--
Others
--
513
526
531
Total Operating Expenses
--
19,031
14,970
17,243
Operating Income or Loss
--
(12,429)
(8,590)
(11,365)
Income from Continuing Operations
Total Other Income/Expenses Net
--
(6,222)
(9,746)
3,206
Earnings Before Interest And Taxes
--
(19,382)
(8,590)
(8,159)
Interest Expense
--
--
--
3,804
Income Before Tax
--
(19,914)
(51,227)
(11,963)
Income Tax Expense
--
0
0
0
Minority Interest
--
--
--
--
Net Income From Continuing Ops
--
(19,914)
(51,227)
(11,963)
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
--
0
0
0
Net Income
--
(19,914)
(51,227)
(11,963)
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
--
(19,914)
(51,227)
(11,963)

 

 

CAREERS

Find out more about opportunities with Zyla Life Sciences.

Career Contact
careers@zyla.com

QUICK LINKS

Sign up for Zyla Life Sciences email alerts.

Investor Contact
ir@zyla.com
Media Contact
media@zyla.com

ZYLA LIFE SCIENCES

U.S. Operations
600 Lee Road, Suite 100
Wayne, PA 19087
Tel: 610.833.4200

© Copyright 2019 Zyla Life Sciences
All rights reserved.